Cumberland Pharmaceuticals (CPIX) Other Non-Current Assets (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Other Non-Current Assets data on file, last reported at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 6.71% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (up 6.71% YoY), and the FY2025 full-year result was $3.0 million, up 6.8% from the prior year.
• Other Non-Current Assets fell to $2.9 million in Q1 2026, from $3.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.2 million in Q1 2022 to a low of $2.4 million in Q3 2022.
• A 5-year average of $2.8 million and a median of $2.8 million in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slipped 27.34% in 2022 and grew 20.24% in 2024, its largest moves.
• Tracing CPIX's Other Non-Current Assets over 5 years: stood at $2.5 million in 2022, then advanced by 6.83% to $2.7 million in 2023, then gained by 3.38% to $2.8 million in 2024, then gained by 6.8% to $3.0 million in 2025, then retreated by 1.59% to $2.9 million in 2026.
• Business Quant data shows CPIX's Other Non-Current Assets at $2.9 million in Q1 2026, $3.0 million in Q4 2025, and $3.0 million in Q3 2025.